Led by the Terry Fox Research Institute and the Terry Fox Foundation
Sasha Main’s team will build data and tools to study circulating tumour DNA, aiming to replace risky and painful tissue biopsies with less invasive blood tests in metastatic breast cancer care.
Learn more: tinyurl.com/mtx6bz2
Sasha Main’s team will build data and tools to study circulating tumour DNA, aiming to replace risky and painful tissue biopsies with less invasive blood tests in metastatic breast cancer care.
Learn more: tinyurl.com/mtx6bz2
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies.
tinyurl.com/bdf7w8cv
Phoebe Lombard will explore how oxygen influences glioblastoma cell behaviour, driving them to become more invasive, more therapy-resistant, or better at evading the immune system.
Learn more▶️ tinyurl.com/7nb9cef3
Phoebe Lombard will explore how oxygen influences glioblastoma cell behaviour, driving them to become more invasive, more therapy-resistant, or better at evading the immune system.
Learn more▶️ tinyurl.com/7nb9cef3
Liquid biopsies are transforming cancer care, but can't yet accurately measure gene expression. Yahan Zhang is creating a machine learning tool that can predict gene expression activity from blood mRNA levels.
Learn more: tinyurl.com/4697997y
Liquid biopsies are transforming cancer care, but can't yet accurately measure gene expression. Yahan Zhang is creating a machine learning tool that can predict gene expression activity from blood mRNA levels.
Learn more: tinyurl.com/4697997y
Don’t miss the next event in our Network Seminar Series
Join us for our next Network Seminar Series event, an inside look at MOHCCN funded research, presented by the Atlantic Cancer Consortium @canceratlantic.bsky.social
Register now: tinyurl.com/4xx2r9k3
Don’t miss the next event in our Network Seminar Series
Join us for our next Network Seminar Series event, an inside look at MOHCCN funded research, presented by the Atlantic Cancer Consortium @canceratlantic.bsky.social
Register now: tinyurl.com/4xx2r9k3
Cancer vaccines rely on neoantigens to guide immune attacks. Vivian Chu’s research finds new sources of these markers, opening doors to more precise, personalized cancer care.
Learn more▶️ tinyurl.com/tjdpa49h
Cancer vaccines rely on neoantigens to guide immune attacks. Vivian Chu’s research finds new sources of these markers, opening doors to more precise, personalized cancer care.
Learn more▶️ tinyurl.com/tjdpa49h
A Toronto-based team led by Drs. Dave Cescon and Mitchell Elliott hope to find new vulnerabilities in ecDNA-positive cancers that could be targeted by new or existing treatments.
🔗Learn more: tinyurl.com/5n8k64p6
A Toronto-based team led by Drs. Dave Cescon and Mitchell Elliott hope to find new vulnerabilities in ecDNA-positive cancers that could be targeted by new or existing treatments.
🔗Learn more: tinyurl.com/5n8k64p6
@terryfoxresearch.bsky.social @terryfoxfoundation.bsky.social
@terryfoxresearch.bsky.social @terryfoxfoundation.bsky.social
*A case is considered complete when full genomic profiling and clinical data are deposited into the MOHCCN.
*A case is considered complete when full genomic profiling and clinical data are deposited into the MOHCCN.
That brings our total number of Full Genomes Profiled to 12,942!
That brings our total number of Full Genomes Profiled to 12,942!
We are closing in on our original goal of collecting 15,000 cases of paired clinical and genomic data from a diverse pool of Canadian cancer patients.
🧵Check out the thread to learn more🧵
We are closing in on our original goal of collecting 15,000 cases of paired clinical and genomic data from a diverse pool of Canadian cancer patients.
🧵Check out the thread to learn more🧵
Learn more: tinyurl.com/mtvrj2v2
Learn more: tinyurl.com/mtvrj2v2
This virtual event will feature updates and scientific talks by Network-funded researchers from across Atlantic Canada.
Register now: tinyurl.com/4xx2r9k3
This virtual event will feature updates and scientific talks by Network-funded researchers from across Atlantic Canada.
Register now: tinyurl.com/4xx2r9k3
A research team led by Dr. Ian Watson will harness the power of MOHCCN's Gold Cohort to identify new mutations that may be responsible for driving cancer.
tinyurl.com/5n7c6ub8
A research team led by Dr. Ian Watson will harness the power of MOHCCN's Gold Cohort to identify new mutations that may be responsible for driving cancer.
tinyurl.com/5n7c6ub8
As a scientist, physician, and cancer patient, Dr. Catalina López-Correa knows both the challenges and the opportunities ahead.
Learn more:
tinyurl.com/22pt6794
As a scientist, physician, and cancer patient, Dr. Catalina López-Correa knows both the challenges and the opportunities ahead.
Learn more:
tinyurl.com/22pt6794
Full statement ▶️ bit.ly/4oSuFhp
Full statement ▶️ bit.ly/4oSuFhp
In our latest Network Voices piece, Bev Riediger shares her cancer journey and a moving poem about what it means to be part of the Patient Working Group.
🔗 Read the complete poem and learn more about Bev's story:
tinyurl.com/43pc6b7p
In our latest Network Voices piece, Bev Riediger shares her cancer journey and a moving poem about what it means to be part of the Patient Working Group.
🔗 Read the complete poem and learn more about Bev's story:
tinyurl.com/43pc6b7p
📆 Oct. 15
🕰️ Local times in poster!
Join this virtual event to learn more about our the Network's impact on research and care in Alberta, Manitoba and Saskatchewan.
🔗 Learn more and register: bit.ly/470yied
📆 Oct. 15
🕰️ Local times in poster!
Join this virtual event to learn more about our the Network's impact on research and care in Alberta, Manitoba and Saskatchewan.
🔗 Learn more and register: bit.ly/470yied
🎆 919 full genomic profiles and clinical data from 1,036 patients were added to our Gold Cohort, the biggest monthly jump ever!
This brings our total number of full genomes sequenced to 11,562 and of complete cases to 6,836!
#FinishIt
🎆 919 full genomic profiles and clinical data from 1,036 patients were added to our Gold Cohort, the biggest monthly jump ever!
This brings our total number of full genomes sequenced to 11,562 and of complete cases to 6,836!
#FinishIt
🔬 Network Seminar Series: Presented by the Prairie Cancer Consortium
📆 Oct. 15
Join this virtual event to learn more about our the Network's impact on research and care in Alberta, Manitoba and Saskatchewan.
🔗 Learn more and register: bit.ly/470yied
🔬 Network Seminar Series: Presented by the Prairie Cancer Consortium
📆 Oct. 15
Join this virtual event to learn more about our the Network's impact on research and care in Alberta, Manitoba and Saskatchewan.
🔗 Learn more and register: bit.ly/470yied
We stand with them in hope and reconciliation today and every day. 🧡
We stand with them in hope and reconciliation today and every day. 🧡
The next event in our Seminar Series is this Thursday, Sept. 18!
Join us to learn more about the incredible research being done by members of our Marathon of Hope - Quebec consortium!
✅ REGISTER NOW! events.teams.microsoft.com/event/2c2e0b...
The next event in our Seminar Series is this Thursday, Sept. 18!
Join us to learn more about the incredible research being done by members of our Marathon of Hope - Quebec consortium!
✅ REGISTER NOW! events.teams.microsoft.com/event/2c2e0b...
Our Seminar Series continues with an upcoming event on Thursday, Sept. 18!
Join us to learn more about the incredible research being done by members of our Marathon of Hope - Quebec consortium!
🔗Register: bit.ly/3HWMJaC
Our Seminar Series continues with an upcoming event on Thursday, Sept. 18!
Join us to learn more about the incredible research being done by members of our Marathon of Hope - Quebec consortium!
🔗Register: bit.ly/3HWMJaC
Drs. Teresa Purzner, Antoine Desilets and Simon Roy will each receive $450,000 to support groundbreaking research in precision oncology after being named recipients of our 2025 Clinician-Scientist Awards!
Learn more about the groundbreaking projects ▶️ bit.ly/4lPyemX
Drs. Teresa Purzner, Antoine Desilets and Simon Roy will each receive $450,000 to support groundbreaking research in precision oncology after being named recipients of our 2025 Clinician-Scientist Awards!
Learn more about the groundbreaking projects ▶️ bit.ly/4lPyemX